Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of
chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients …

Sonazoid, a second-generation ultrasound contrast agent, was introduced for the diagnosis
of hepatic nodules. To clarify the issues with Sonazoid contrast-enhanced ultrasonography …

Purpose: Synergistic effect of radiotherapy and immunotherapy for the treatment of
hepatocellular carcinoma (HCC) has been reported. This phase I/IIa pilot trial evaluated …

Background Adjuvant therapy may improve survival of patients with hepatocellular
carcinoma (HCC) after curative resection. This study compared safety and efficacy outcomes …

Background US is a standard surveillance tool of hepatocellular carcinoma (HCC), but its
effectiveness varies depending on the degree of fibrosis or steatosis and the etiologies of …

Simple Summary We aimed to compare the prognosis of patients with advanced
hepatocellular carcinoma treated with the first-line atezolizumab plus bevacizumab (AB) …

The aim of this study was to identify the treatment status and natural prognosis of
hepatocellular carcinoma (HCC) patients aged 65 years or older in Korea. We analyzed …

Radiofrequency ablation (RFA) has been widely used to manage hepatocellular carcinomas
(HCCs) equal to or smaller than 3 cm. No-touch RFA has gained attention and has recently …

Background and Aims Nivolumab was the first immune checkpoint inhibitor approved for
hepatocellular carcinoma (HCC). External beam radiation therapy (EBRT) is locally effective …

Hepatocellular carcinoma (HCC) is a deadly and burdensome form of liver cancer with an
increasing global prevalence. Its course is unpredictable as it frequently occurs in the …